一项针对I期非小细胞肺癌（NSCLC）高危患者的肺叶下切除（SR）与立体定向消融放疗（SAbR）的随机III期研究。 - Suppr

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

作者信息

Teke Martha E, Sarvestani Amber Leila, Hernandez Jonathan M, Fernando Hiran C, Timmerman Robert D

机构信息

Surgical Oncology Program, National Cancer Institute, NationalInstitutesofHealth, Building 10, Room 4-3740, Bethesda, MD, 20892, USA.

Division of Thoracic Surgery, Department of Thoracic and Cardiovascular Surgery, Allegheny Health Network, Pittsburgh, PA, USA.

出版信息

Ann Surg Oncol. 2022 Aug;29(8):4686-4687. doi: 10.1245/s10434-022-11584-3. Epub 2022 May 6.

DOI:10.1245/s10434-022-11584-3

PMID:35524087

Abstract

摘要

相似文献

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

Ann Surg Oncol. 2022 Aug;29(8):4686-4687. doi: 10.1245/s10434-022-11584-3. Epub 2022 May 6.

Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?

Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):845-53. doi: 10.1093/icvts/ivt262. Epub 2013 Jul 30.

Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age.

Thorac Cancer. 2019 Jun;10(6):1489-1499. doi: 10.1111/1759-7714.13103. Epub 2019 May 23.

Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.

JAMA Surg. 2014 Dec;149(12):1244-53. doi: 10.1001/jamasurg.2014.556.

SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

Curr Treat Options Oncol. 2016 Jun;17(6):27. doi: 10.1007/s11864-016-0407-3.

Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.

Clin Oncol (R Coll Radiol). 2019 Oct;31(10):681-687. doi: 10.1016/j.clon.2019.07.013. Epub 2019 Jul 31.

Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.

Oncologist. 2014 Aug;19(8):880-5. doi: 10.1634/theoncologist.2013-0469. Epub 2014 Jun 20.

Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):348-53. doi: 10.1016/j.ijrobp.2011.06.2003. Epub 2011 Nov 19.

Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

JAMA Oncol. 2019 May 1;5(5):681-688. doi: 10.1001/jamaoncol.2018.6993.

Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England.

Thorax. 2020 Mar;75(3):237-243. doi: 10.1136/thoraxjnl-2018-212493. Epub 2019 Dec 26.

引用本文的文献

Surgery or radiotherapy for early-stage cancer study (SORT) target trial protocol: stereotactic ablative radiotherapy (SABR) with curative intent versus surgical resection for early-stage non-small cell lung cancer (NSCLC).

BMJ Open. 2025 Jul 13;15(7):e103038. doi: 10.1136/bmjopen-2025-103038.

A Retrospective Study on the Long-Term Outcomes of Stereotactic Ablative Radiotherapy Versus Sublobar Resection in Lung Cancer: Analysis From the Scottish Cancer Registry.

Cureus. 2024 Sep 22;16(9):e69927. doi: 10.7759/cureus.69927. eCollection 2024 Sep.

Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer.

Sci Rep. 2023 Jun 27;13(1):10384. doi: 10.1038/s41598-023-37643-7.

Surgery versus radiotherapy in octogenarians with stage Ia non‑small cell lung cancer: propensity score matching analysis of the SEER database.

BMC Pulm Med. 2022 Nov 10;22(1):411. doi: 10.1186/s12890-022-02177-7.

Resect a little, resect more, irradiate or ablate-what is the best approach?

J Thorac Dis. 2022 Sep;14(9):3108-3110. doi: 10.21037/jtd-22-1099.

Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety.

Front Oncol. 2022 Aug 22;12:976777. doi: 10.3389/fonc.2022.976777. eCollection 2022.

Influence of Dexamethasone Premedication on Acute Lung Toxicity in Lung SBRT.

Front Oncol. 2022 Feb 28;12:837577. doi: 10.3389/fonc.2022.837577. eCollection 2022.

Recent advances in early stage lung cancer.

J Clin Transl Res. 2021 Apr 6;7(2):163-174. eCollection 2021 Apr 22.

Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT.

J Appl Clin Med Phys. 2019 Mar;20(3):7-13. doi: 10.1002/acm2.12545. Epub 2019 Feb 22.

Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2451-S2464. doi: 10.21037/jtd.2018.04.52.

本文引用的文献

Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.

J Thorac Cardiovasc Surg. 2020 Nov;160(5):1350-1357.e11. doi: 10.1016/j.jtcvs.2019.11.132. Epub 2019 Dec 26.

Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).

Lancet Respir Med. 2018 Dec;6(12):915-924. doi: 10.1016/S2213-2600(18)30411-9. Epub 2018 Nov 12.

Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.

JAMA Oncol. 2018 Sep 1;4(9):1263-1266. doi: 10.1001/jamaoncol.2018.1251.

Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.

Cancer. 2018 Feb 15;124(4):667-678. doi: 10.1002/cncr.31196. Epub 2017 Dec 19.

Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer.

Ann Cardiothorac Surg. 2014 Mar;3(2):134-41. doi: 10.3978/j.issn.2225-319X.2014.03.08.

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.

J Clin Oncol. 2009 Jul 10;27(20):3290-6. doi: 10.1200/JCO.2008.21.5681. Epub 2009 May 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

作者信息

Teke Martha E, Sarvestani Amber Leila, Hernandez Jonathan M, Fernando Hiran C, Timmerman Robert D

机构信息

Surgical Oncology Program, National Cancer Institute, NationalInstitutesofHealth, Building 10, Room 4-3740, Bethesda, MD, 20892, USA.

Division of Thoracic Surgery, Department of Thoracic and Cardiovascular Surgery, Allegheny Health Network, Pittsburgh, PA, USA.

出版信息

Ann Surg Oncol. 2022 Aug;29(8):4686-4687. doi: 10.1245/s10434-022-11584-3. Epub 2022 May 6.

DOI:10.1245/s10434-022-11584-3

PMID:35524087

Abstract

摘要

相似文献

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

Ann Surg Oncol. 2022 Aug;29(8):4686-4687. doi: 10.1245/s10434-022-11584-3. Epub 2022 May 6.

Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?

Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):845-53. doi: 10.1093/icvts/ivt262. Epub 2013 Jul 30.

Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age.

Thorac Cancer. 2019 Jun;10(6):1489-1499. doi: 10.1111/1759-7714.13103. Epub 2019 May 23.

Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.

JAMA Surg. 2014 Dec;149(12):1244-53. doi: 10.1001/jamasurg.2014.556.

SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

Curr Treat Options Oncol. 2016 Jun;17(6):27. doi: 10.1007/s11864-016-0407-3.

Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.

Clin Oncol (R Coll Radiol). 2019 Oct;31(10):681-687. doi: 10.1016/j.clon.2019.07.013. Epub 2019 Jul 31.

Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.

Oncologist. 2014 Aug;19(8):880-5. doi: 10.1634/theoncologist.2013-0469. Epub 2014 Jun 20.

Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):348-53. doi: 10.1016/j.ijrobp.2011.06.2003. Epub 2011 Nov 19.

Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

JAMA Oncol. 2019 May 1;5(5):681-688. doi: 10.1001/jamaoncol.2018.6993.

Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England.

Thorax. 2020 Mar;75(3):237-243. doi: 10.1136/thoraxjnl-2018-212493. Epub 2019 Dec 26.

引用本文的文献

BMJ Open. 2025 Jul 13;15(7):e103038. doi: 10.1136/bmjopen-2025-103038.

A Retrospective Study on the Long-Term Outcomes of Stereotactic Ablative Radiotherapy Versus Sublobar Resection in Lung Cancer: Analysis From the Scottish Cancer Registry.

Cureus. 2024 Sep 22;16(9):e69927. doi: 10.7759/cureus.69927. eCollection 2024 Sep.

Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer.

Sci Rep. 2023 Jun 27;13(1):10384. doi: 10.1038/s41598-023-37643-7.

Surgery versus radiotherapy in octogenarians with stage Ia non‑small cell lung cancer: propensity score matching analysis of the SEER database.

BMC Pulm Med. 2022 Nov 10;22(1):411. doi: 10.1186/s12890-022-02177-7.

Resect a little, resect more, irradiate or ablate-what is the best approach?

J Thorac Dis. 2022 Sep;14(9):3108-3110. doi: 10.21037/jtd-22-1099.

Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety.

Front Oncol. 2022 Aug 22;12:976777. doi: 10.3389/fonc.2022.976777. eCollection 2022.

Influence of Dexamethasone Premedication on Acute Lung Toxicity in Lung SBRT.

Front Oncol. 2022 Feb 28;12:837577. doi: 10.3389/fonc.2022.837577. eCollection 2022.

Recent advances in early stage lung cancer.

J Clin Transl Res. 2021 Apr 6;7(2):163-174. eCollection 2021 Apr 22.

Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT.

J Appl Clin Med Phys. 2019 Mar;20(3):7-13. doi: 10.1002/acm2.12545. Epub 2019 Feb 22.

Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2451-S2464. doi: 10.21037/jtd.2018.04.52.

本文引用的文献

Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.

J Thorac Cardiovasc Surg. 2020 Nov;160(5):1350-1357.e11. doi: 10.1016/j.jtcvs.2019.11.132. Epub 2019 Dec 26.

Lancet Respir Med. 2018 Dec;6(12):915-924. doi: 10.1016/S2213-2600(18)30411-9. Epub 2018 Nov 12.

Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.

JAMA Oncol. 2018 Sep 1;4(9):1263-1266. doi: 10.1001/jamaoncol.2018.1251.

Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.

Cancer. 2018 Feb 15;124(4):667-678. doi: 10.1002/cncr.31196. Epub 2017 Dec 19.

Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer.

Ann Cardiothorac Surg. 2014 Mar;3(2):134-41. doi: 10.3978/j.issn.2225-319X.2014.03.08.

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.

J Clin Oncol. 2009 Jul 10;27(20):3290-6. doi: 10.1200/JCO.2008.21.5681. Epub 2009 May 4.

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献